Aeris Capital logo

Aeris Capital

Europe, Zurich, Switzerland, Pfaffikon

Description

Aeris Capital AG operates as a distinguished multi-family office and financial advisor, catering to a select group of entrepreneurial families. Headquartered in Pfaffikon, Switzerland, the firm maintains a significant presence in the United States with an office in Palo Alto, California. This dual geographic footprint allows Aeris Capital to access diverse investment opportunities across global markets, leveraging its expertise in wealth management and strategic financial guidance.

The firm's investment strategy is notably broad and diversified, encompassing direct investments in private equity, venture capital, and real estate. Beyond direct participation, Aeris Capital also allocates capital through fund-of-funds structures, demonstrating a comprehensive approach to asset management. Their direct investment focus primarily targets high-growth sectors such as technology, healthcare, and sustainable energy, reflecting a commitment to innovation and long-term value creation.

Aeris Capital is characterized by its patient and long-term capital approach, often acting as a strategic partner to its portfolio companies. While specific details on individual investment sizes are not always publicly disclosed, their participation in various stages, from early-stage venture rounds to more mature private equity deals, suggests a flexible investment capacity. For direct venture and private equity investments, Aeris Capital typically deploys first cheques ranging from approximately $1 million for early-stage opportunities up to $25 million for more significant growth equity or private equity transactions. This wide range underscores their adaptability to different deal sizes and stages.

As a sophisticated investor, Aeris Capital AG provides more than just capital; it offers strategic advisory services and leverages its extensive network to support the growth and success of its portfolio companies. Their commitment to fostering long-term relationships and contributing to the strategic direction of their investments positions them as a valuable partner for founders and management teams seeking patient, informed capital.

Investor Profile

Aeris Capital has backed more than 39 startups, with 0 new investments in the last 12 months alone. The firm has led 15 rounds, about 38% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Germany, Canada.
  • Strong thematic focus on Health Care, Medical, Biotechnology.
  • Typical check size: $1M – $25M.

Stage Focus

  • Series C (26%)
  • Series D (21%)
  • Series A (18%)
  • Series B (10%)
  • Series Unknown (8%)
  • Series E (8%)
  • Private Equity (5%)
  • Post Ipo Equity (3%)
  • Seed (3%)

Country Focus

  • United States (67%)
  • Germany (21%)
  • Canada (8%)
  • Switzerland (3%)
  • Israel (3%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Mobile
  • Therapeutics
  • Genetics
  • Advertising
  • Advertising Platforms
  • Native Advertising
  • Publishing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aeris Capital frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Mohr Davidow Ventures
North America, California, United States, San Mateo
Co-Investments: 5
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 3
Aberdare Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Employee Stock Option Fund
North America, California, United States, San Mateo
Co-Investments: 2
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 4
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 4
GE Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 4
Venrock
North America, California, United States, Palo Alto
Co-Investments: 3

Which angels does Aeris Capital often collaborate with?

DC
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
JM
North America, Florida, United States, Miami
Shared Deals: 1
Benjamin Kahn
Asia, Israel
Shared Deals: 1

What are some of recent deals done by Aeris Capital?

GenomeDx Biosciences

Vancouver, British Columbia, Canada

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care.

BiotechnologyGeneticsHealth CareMedicalOncologyPrecision Medicine
Series UnknownJun 27, 2017
Amount Raised: $6,254,241
Jiff

Mountain View, California, United States

Jiff is an enterprise health benefits platform that saves employers money.

Health CareMedicalMobile
Series CJun 7, 2016
Amount Raised: $17,700,000
Solstice Biologics

San Francisco, California, United States

Solstice Biologics is a biotech company that provides solutions for targeting and delivering nucleic acid therapeutics.

BiotechnologyMedicalTherapeutics
Series CDec 30, 2015
Amount Raised: $4,000,000
Affimed

Heidelberg, Baden-Wurttemberg, Germany

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

BiotechnologyClinical TrialsHealth CareMedicalTherapeutics
Post Ipo EquityOct 1, 2015
Amount Raised: $21,376,011
Jiff

Mountain View, California, United States

Jiff is an enterprise health benefits platform that saves employers money.

Health CareMedicalMobile
Series CMay 21, 2015
Amount Raised: $23,300,000
Curetis

Holzgerlingen, Baden-Wurttemberg, Germany

Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.

BiotechnologyGeneticsHealth DiagnosticsMedical
Series BNov 20, 2014
Amount Raised: $18,187,725
Butterfly Network

Burlington, Massachusetts, United States

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

ElectronicsHealth CareMedical DevicePersonal Health
Series UnknownNov 2, 2014
Amount Raised: $100,000,000
Jiff

Mountain View, California, United States

Jiff is an enterprise health benefits platform that saves employers money.

Health CareMedicalMobile
Series BSep 23, 2014
Amount Raised: $18,300,000
Affimed

Heidelberg, Baden-Wurttemberg, Germany

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

BiotechnologyClinical TrialsHealth CareMedicalTherapeutics
Series ESep 2, 2014
Amount Raised: $15,700,000
Smaato

New York, New York, United States

Smaato is a digital ad tech platform that offers a free ad server and monetization solution.

AdvertisingAdvertising PlatformsMobileNative AdvertisingPublishing
Series EAug 5, 2014
Amount Raised: $25,000,000